MAPT V363I variation in a sporadic case of frontotemporal dementia: variable penetrant mutation or rare polymorphism?

Maria Anfossi1, Livia Bernardi, Maura Gallo

  • 1Regional Neurogenetic Centre, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Insights

The V363I tau gene variation was found in a frontotemporal dementia patient and family. Its role in disease suggests genetic modifiers may influence neurodegenerative conditions.

Area of Science:

  • Neurogenetics
  • Neurodegenerative Diseases

Background:

  • The V363I mutation in the microtubule-associated protein tau gene is linked to primary progressive nonfluent aphasia with variable penetrance.
  • Frontotemporal dementia (FTD) is a group of progressive neurodegenerative disorders.

Observation:

  • The V363I tau gene variation was identified in a patient with sporadic early-onset frontotemporal dementia and in family members.
  • The V363I variation was associated with FTD only in the proband.

Findings:

  • The proband was homozygous for the progranulin single-nucleotide polymorphism rs9897526 (A allele) and methionine at codon 129 of the prion protein gene.
  • The V363I tau variation's pathogenicity is unclear, potentially acting as an incomplete penetrant mutation or rare polymorphism.
  • Genetic modifier factors may contribute to the observed pathogenic effects in the patient.

Implications:

  • This case challenges the definition of sporadic neurodegenerative diseases, suggesting potential underlying genetic mutations.
  • Understanding genetic modifiers is crucial for unraveling the complexity of neurodegenerative diseases like FTD.
  • Further research is needed to clarify the V363I variation's role and the influence of genetic modifiers in FTD pathogenesis.

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Mutations01:39

Mutations

Overview